Digna Biotech, S.L.
Industry
- Biotechnology
- Pharmaceuticals
See more in Biomedtracker
Latest on Digna Biotech, S.L.
Pink Sheet
• By John Davis
With just eight weeks of cash and a lead product that six months ago failed to win European approval, the Euronext-listed gene therapy company Amsterdam Molecular Therapeutics BV (AMT) has announc
In Vivo
Mergers & Acquisitions /In Vitro Diagnostics Clovis Oncology Inc. Roche Roche Diagnostics Roche Molecular Systems Inc. On the same day it received rights to a solid tumor compound from Pfizer Inc.
In Vivo
In Vitro Diagnostics Alliances / In Vitro Diagnostics Genomic Health Inc. Genomic Health (oncogenomics diagnostics) netted $43.3mm through the follow-on public offering of 3mm common shares at $15.